Tagworks Pharmaceuticals

Tagworks is focused on revolutionizing cancer therapies by in vivo chemical manipulation of the therapeutic window across a range of treatment modalities such as antibody drug conjugates (Rossin et al., Nature Comm., 9.1 (2018): 1-11) and targeted radiotherapy. The Tagworks technology is based on the proprietary Click-to-Release reaction, which is so far the only bioorthogonal cleavage reaction with clinical potential.